Back to results
US 2026/0028397 A1Published application
Methods of treating ankylosing spondylitis
AssigneeAcelyrin, Inc.
InventorsShao-Lee Lin, Paul Peloso
Life of this patent
Estimating the term…
Abstract
The disclosure relates to novel regimens for treating an inflammatory arthiritis. e.g., psoriatic arthritis. which employ a therapeutically effective amount of an Interleukin- 17 (IL-17) antagonist. e.g., IL-17 binding molecule (e.g., IL-17 antibody or antigen binding fragment thereof. e.g., secukinumab) or IL-17 receptor binding molecule (e.g., IL-17 antibody or antigen binding fragment thereof).
Claims20
A method for treatment of ankylosing spondylitis:
- the method comprising administering to a patient a therapeutically effective amount of pharmaceutical composition comprising a bispecific fusion protein, wherein the bispecific fusion protein comprises an IL-17A binding motif and an albumin binding motif.
(canceled)
-14. (canceled)
-19. (canceled)
-24. (canceled)
(canceled)
-35. (canceled)
Dependencies are inferred from the claim text.